Trial Profile
Treatment With Donepezil of Chronic Aphasia and Sensorimotor Deficits Associated to Cerebrovascular Accidents: a Double-Blind,Placebo-Controlled, Randomized Parallel Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2009
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Aphasia
- Focus Therapeutic Use
- 22 May 2009 New trial record